In October 2024, nine seed rounds raised a total of $146 million (Labiotech, Oct 2024).
Since there is already a separate question for the global funding (where this statement is repeated verbatim), one would arguably expect that such a statement in this question is about the US only (and @PeterStamp's implicit conclusion below that we had a super-October in 2024 with $146 million applicable here is perfectly understandable, under the circumstances). But there is nothing in the linked article indicating that this number is for US companies only - on the contrary, it seems to refer to global seed funding (best case, it is definitely unclear).
And I am afraid it gets worse: looking at October in their 2024 tracker (unfolding the 'Recent biotech seed fundings' section), the sum of the reported rounds (which are 6, not 9, with the majority of companies being from Germany and the UK) is just short of ~$80 million, and in no way $146 million. The share of US companies was just $37.2 million...
For example, in August 2024, there were six seed rounds totaling $48 million (Labiotech, Aug 2024).
According to their own 2024 tracker, we had indeed 6 seed rounds in August 2024 (and as it happened, all six were for US companies), but summing up manually the seed funding amounts reported there gives $78.7 million, not $48 million...
U.S. startups raised $304.8 million in seed funding in 2024.
I can confirm that manually adding the seed funding amounts reported in their 2024 tracker for US companies gives indeed $304.8 million.
Bottom line: their 2024 tracker seems unreliable - it is actually contradicted by their own articles of Oct 2024 and Aug 2024 (and I can only suspect that if I look at their other monthly articles I will find similar discrepancies).
@ctsats The articles reference Crunchbase data instead of the Labiotech tracker the question asks about. We've removed these sentences to avoid confusion.
Since there is already a separate question for the global funding (where this statement is repeated verbatim), one would arguably expect that such a statement in this question is about the US only (and @PeterStamp's implicit conclusion below that we had a super-October in 2024 with $146 million applicable here is perfectly understandable, under the circumstances). But there is nothing in the linked article indicating that this number is for US companies only - on the contrary, it seems to refer to global seed funding (best case, it is definitely unclear).
And I am afraid it gets worse: looking at October in their 2024 tracker (unfolding the 'Recent biotech seed fundings' section), the sum of the reported rounds (which are 6, not 9, with the majority of companies being from Germany and the UK) is just short of ~$80 million, and in no way $146 million. The share of US companies was just $37.2 million...
According to their own 2024 tracker, we had indeed 6 seed rounds in August 2024 (and as it happened, all six were for US companies), but summing up manually the seed funding amounts reported there gives $78.7 million, not $48 million...
I can confirm that manually adding the seed funding amounts reported in their 2024 tracker for US companies gives indeed $304.8 million.
Bottom line: their 2024 tracker seems unreliable - it is actually contradicted by their own articles of Oct 2024 and Aug 2024 (and I can only suspect that if I look at their other monthly articles I will find similar discrepancies).